IPOs and Secondaries
IPOs and Secondaries Articles
Citigroup has announced a definitive agreement with Springleaf Holdings regarding the sale of OneMain Financial Holdings for $4.25 billion.
Published:
Goodrich Petroleum announced Monday morning that it would have a secondary public offering of 12 million shares.
Published:
Last Updated:
Last week was a downer for initial public offerings. Perhaps the action will pick up a bit in the coming week with a couple of new IPOs scheduled to begin trading.
Published:
Last Updated:
Biocept has seen its stock move up over 200% in the past week, only to give back about 20% in Thursday's trading.
Published:
At the right price, Alibaba probably is a tremendous long-term stock to have in an aggressive growth portfolio. The question is, what is that price?
Published:
Atlantic Alliance Partnership has filed with the U.S. Securities and Exchange Commission for its initial public offering.
Published:
Health Care REIT has priced its underwritten public secondary offering of 17 million shares, but some investors may be wondering if it priced the offering too low.
Published:
Only one IPO decorates this week’s calendar, Wowo Ltd., a China-based lifestyle, e-commerce platform.
Published:
Last Updated:
SolarEdge Technologies has filed with the U.S. Securities and Exchange Commission for its initial public offering.
Published:
Neurocrine Biosciences has announced that it will have another public offering of its common stock to raise roughly $225 million.
Published:
Midstream master limited partnership (MLP) Phillips 66 Partners on Tuesday priced an underwritten secondary offering of 5.25 million limited partnership units.
Published:
Last Updated:
Box just ended the quiet period following its initial public offering , and analysts have begun to weigh in on this data storage company.
Published:
Here is a look at the initial public offerings on the schedule for the coming week, including Infraredx, Inotek Pharmaceuticals and Wowo.
Published:
Last Updated:
Quantum Fuel Systems Technologies Worldwide has raised almost $10 million in net capital in a secondary offering.
Published:
Specialty pharmaceutical company SteadyMed has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering.
Published: